WO2018154102A1 - Cooling compositions - Google Patents

Cooling compositions Download PDF

Info

Publication number
WO2018154102A1
WO2018154102A1 PCT/EP2018/054633 EP2018054633W WO2018154102A1 WO 2018154102 A1 WO2018154102 A1 WO 2018154102A1 EP 2018054633 W EP2018054633 W EP 2018054633W WO 2018154102 A1 WO2018154102 A1 WO 2018154102A1
Authority
WO
WIPO (PCT)
Prior art keywords
menthanecarboxamide
liquid
product
composition
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2018/054633
Other languages
French (fr)
Inventor
Angus Peter Macmaster
Tracy BARTHOLOMEW
Stephen David Watkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
Givaudan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan SA filed Critical Givaudan SA
Publication of WO2018154102A1 publication Critical patent/WO2018154102A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24Thermal properties
    • A61K2800/244Endothermic; Cooling; Cooling sensation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/49Solubiliser, Solubilising system

Definitions

  • This disclosure relates to cooling compounds and more particularly to compositions of such cooling compounds and to products containing such compositions.
  • Synthetic cooling compounds that is, compounds that produce a cooling sensation on the skin or the mucous membranes have been long known, and a wide variety of such compounds is now available.
  • a problem with many of these compounds is that, not only are they crystalline solids, but also that they are relatively insoluble in nearly everything,
  • EvercoolTM190 and hereinafter referred to respectively by the designations "180" and
  • liquid cooling composition that is a mixture of (N-(4-cyanomethylphenyl) p- menthanecarboxamide, N-(2-pyridin-2-ylethyl) p-menthanecarboxamide and menthyl lactate, the composition being characterized in that, in a triangular ternary phase diagram 30 of (N-(4-cyanomethyl-phenyl) p-menthanecarboxamide, N-(2-pyridin-2-ylethyl) p- menthanecarboxamide and menthyl lactate, the composition falls within that portion of the diagram bounded by the coordinates of the following table:
  • the composition comprises all three materials.
  • compositions of cooling compounds are room-temperature eutectics, that is, they are liquid without the need for the addition of solvent. Not only does this mean reduced expense, but also that it is possible to get into products more of 180 and 190, both of which are poorly soluble in the normal solvents of the art.
  • compositions remain liquid when stored for long periods. This makes manufacture and utilization very easy and allows the provision of an excellent cooling effect.
  • a particular embodiment includes the compositions defined on the ternary phase diagram as follows:
  • a further particular embodiment is as follows: menthyl lactate (N-(4-cyanomethylphenyl) N-(2-pyridin-2-ylethyl) p- p-menthanecarboxamide, menthanecarboxamide
  • a further particular embodiment is as follows: menthyl lactate (N-(4-cyanomethylphenyl) N-(2-pyridin-2-ylethyl) p- p-menthanecarboxamide, menthanecarboxamide
  • compositions are prepared by blending the desired components, heating them until they melt and then allowing the mixture to cool to ambient temperature.
  • compositions may be pre-blended and stored. Not only are they liquid, making them easier to add and incorporate into compositions, but they are also remarkably stable.
  • compositions may be added to any products in which a cooling effect on the skin or mucous membranes is desired. All three have been certified as GRAS (generally recognized as safe) by the US FEMA (Flavor and Extracts Manufacturers Association), the standard for use in consumable compositions, making them usable in any kind of product taken by mouth.
  • GRAS Generally recognized as safe
  • US FEMA Frute and Extracts Manufacturers Association
  • Non-limiting examples of products include the following: - Products that are applied to the oral mucosa, but that are not limited to foodstuffs and beverages taken into the mouth and swallowed, and products taken for reasons other than their nutritional value, e.g. tablets, troches, mouthwash, throat sprays, dentifrices and chewing gums, which may be applied to the oral mucosa for the purpose of cleaning, freshening, healing, and/or deodorising.
  • Products that are applied to the skin include, but are not limited to perfumes, toiletries, cosmetic products such as lotions, oils, ointments and bathing agents, applicable to the skin of the human body, whether for medical or other reasons.
  • foodstuffs and beverages include, but are not limited to frozen confectionery such as ice creams and sorbets; desserts such as jelly and pudding;
  • confectionery such as cakes, cookies, chocolates, and chewing gum; jams; candies; breads; tea beverages such as green tea, black tea, chamomile tea, mulberry leaf tea, Rooibos tea, peppermint tea; soups; seasonings; instant beverages; snack foods and the like.
  • products for topical application may include, but are not limited to, skin-care cosmetics such as cleansing tissues, talcum powders, face creams, lotions, tonics and gels; hand creams, hand- and body lotions, anti-cellulite/slimming creams and -lotions, lotions, balms, gels, sprays and creams; sunburn cosmetics including sunscreen lotions, balms, gels, sprays and creams; after sun lotions, sprays and creams; soaps, toothpicks, lip sticks, agents for bathing, deodorants and antiperspirants, face washing creams, massage creams, and the like
  • Further examples of products that are applied to the oral mucosa may include, but are not limited to, oral care products such as toothpastes, tooth gels, tooth powders, tooth whitening products, dental floss, anti-plaque and anti-gingivitis compositions,
  • compositions for treatment of nasal symptoms and the like.
  • the compositions have been found to be particularly useful and effective in such oral care products.
  • compositions of the invention may be added to and incorporated into a product base by known methods. Sufficient may be added to provide a cooling effect. The necessary proportion to provide such an effect will naturally depend on the desired cooling effect, but typical weight proportions being from 5 to 5000mg/kg, more particularly from 50 to
  • a product adapted to provide a cooling effect on the skin or the mucous membranes the composition comprising a product base and a cooling proportion of a liquid cooling composition as hereinabove described.
  • a method of providing to a product a cooling sensation for the skin or the mucous membranes comprising the addition to a product base of a cooling proportion of a liquid cooling composition as hereinabove described.
  • product base is meant all the components of a product other than the liquid cooling mixture. These can vary considerably, depending on the nature of the product. For example, a consumable product cannot have non-consumable ingredients.
  • Typical non-limiting examples of components for use in product bases include matrix materials both liquid and solid, including gums, starches and starch derivatives, polysaccharides and polymeric materials both natural and artificial, flavours and fragrances, pigments, dyestuffs and colouring matters, solvents, thickeners, rheology and viscosity modifiers, surfactants and dispersion aids, preservatives, bactericides and fungicides.
  • matrix materials both liquid and solid, including gums, starches and starch derivatives, polysaccharides and polymeric materials both natural and artificial, flavours and fragrances, pigments, dyestuffs and colouring matters, solvents, thickeners, rheology and viscosity modifiers, surfactants and dispersion aids, preservatives, bactericides and fungicides.
  • the final product not only has an enhanced cooling effect with respect to the addition of the equivalent amount of powder, but it is also is free from the potentially irritant effects of undissolved powders on skin on mu
  • the handling of the liquid blend during manufacture of products is much easier than with powders, a feature that is particularly significant on an industrial scale, in which the handling of powders, especially those of potent cooling compounds, present a potentially considerable irritant problem for workers, as well as a potential explosion hazard.
  • the disclosure is further described with reference to the following non-limiting examples.
  • Figure 1 depicts a ternary phase diagram, defining the outer limits of the claimed range of compositions.
  • Figure 2 depicts a further ternary phase diagram, defining a particular embodiment of the claimed range of compositions.
  • Figure 3 depicts a further ternary phase diagram, defining a particular embodiment of th claimed range of compositions.
  • Figure 4 depicts a further ternary phase diagram, defining a particular embodiment of th claimed range of compositions.
  • Liquid Liquid Liquid 50 20
  • Liquid + Solids - 10 80
  • Liquid Liquid Liquid 30 60
  • 10 Liquid + Solids - 70 20
  • a mouthwash base was prepared by combining the following components...
  • the addition of the liquid blend was much easier than with the powder, and the final product is free from the potentially irritant effects of undissolved powders on skin on mucous membranes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

A liquid cooling composition that is a mixture of (N-(4-cyanomethylphenyl) p-menthanecarboxamide, N-(2-pyridin-2-ylethyl) p-menthanecarboxamide and menthyl lactate, the composition being characterized in that, in a triangular ternary phase diagram of (N-(4-cyanomethyl-phenyl) p-menthanecarboxamide, N-(2-pyridin-2-ylethyl) p-menthanecarboxamide and menthyl lactate, the composition falls within that portion of the diagram bounded by the coordinates of the following table (l). The compositions are stable liquids, able to be stored and easily incorporated into products, and giving superior cooling properties with respect to the same quantities of compounds added as powders.

Description

COOLING COMPOSITIONS
This disclosure relates to cooling compounds and more particularly to compositions of such cooling compounds and to products containing such compositions.
5
Synthetic cooling compounds, that is, compounds that produce a cooling sensation on the skin or the mucous membranes have been long known, and a wide variety of such compounds is now available. A problem with many of these compounds is that, not only are they crystalline solids, but also that they are relatively insoluble in nearly everything,
10 and it is therefore difficult to get sufficient into solution in products utilizing them to
produce the desired cooling effect. This has been a particular problem with the recently- introduced (N-(4-cyanomethylphenyl) p-menthanecarboxamide and N-(2-pyridin-2-ylethyl) p-menthanecarboxamide (commercialized respectively as Evercool™ 180 and
Evercool™190, and hereinafter referred to respectively by the designations "180" and
15 "190"), but other cooling compounds have suffered from the same problem to a greater or lesser extent.
One attempt to get more into solution was described in International publication WO 2007/140783, in which primary and secondary cooling compounds, including the 180 and 20 190, are combined with non-polar solvents in particular ratios. Mixtures of 180 and 190 are also described in WO 2012/1 13873, but in connection with lowering the proportion of menthol used in a flavour composition, rather than getting more into solution.
It has now been found that it is possible to combine certain solid cooling compounds to 25 provide a liquid cooling composition that is exceptionally stable on storage and that
provides useful cooling properties to a wide variety of products. There is therefore provided a liquid cooling composition that is a mixture of (N-(4-cyanomethylphenyl) p- menthanecarboxamide, N-(2-pyridin-2-ylethyl) p-menthanecarboxamide and menthyl lactate, the composition being characterized in that, in a triangular ternary phase diagram 30 of (N-(4-cyanomethyl-phenyl) p-menthanecarboxamide, N-(2-pyridin-2-ylethyl) p- menthanecarboxamide and menthyl lactate, the composition falls within that portion of the diagram bounded by the coordinates of the following table:
35 menthyl lactate (N-(4-cyanomethylphenyl) N-(2-pyridin-2-ylethyl) p- p-menthanecarboxamide, menthanecarboxamide
100 0 0
80 20 0
0 31 .5 68.5
0 0 100
In a particular embodiment, the composition comprises all three materials.
Ternary phase diagrams having the form of a equilateral triangle and depicting a three- component system with one component per apex representing 100% of one component and a line from that apex perpendicular to the opposing side as the axis of that component are well known to the art and are standard methods of depicting such compositions.
Examples may be found in the figures. It is a particular feature of this disclosure that these compositions of cooling compounds are room-temperature eutectics, that is, they are liquid without the need for the addition of solvent. Not only does this mean reduced expense, but also that it is possible to get into products more of 180 and 190, both of which are poorly soluble in the normal solvents of the art.
A further unexpected advantage is that these compositions remain liquid when stored for long periods. This makes manufacture and utilization very easy and allows the provision of an excellent cooling effect. A particular embodiment includes the compositions defined on the ternary phase diagram as follows:
Figure imgf000003_0001
A further particular embodiment is as follows: menthyl lactate (N-(4-cyanomethylphenyl) N-(2-pyridin-2-ylethyl) p- p-menthanecarboxamide, menthanecarboxamide
80 10 10
10 20 60
20 0 80
A further particular embodiment is as follows: menthyl lactate (N-(4-cyanomethylphenyl) N-(2-pyridin-2-ylethyl) p- p-menthanecarboxamide, menthanecarboxamide
20 20 60
40 20 40
50 10 40
20 10 70
The compositions are prepared by blending the desired components, heating them until they melt and then allowing the mixture to cool to ambient temperature.
The compositions may be pre-blended and stored. Not only are they liquid, making them easier to add and incorporate into compositions, but they are also remarkably stable.
The compositions may be added to any products in which a cooling effect on the skin or mucous membranes is desired. All three have been certified as GRAS (generally recognized as safe) by the US FEMA (Flavor and Extracts Manufacturers Association), the standard for use in consumable compositions, making them usable in any kind of product taken by mouth.
Non-limiting examples of products include the following: - Products that are applied to the oral mucosa, but that are not limited to foodstuffs and beverages taken into the mouth and swallowed, and products taken for reasons other than their nutritional value, e.g. tablets, troches, mouthwash, throat sprays, dentifrices and chewing gums, which may be applied to the oral mucosa for the purpose of cleaning, freshening, healing, and/or deodorising. Products that are applied to the skin include, but are not limited to perfumes, toiletries, cosmetic products such as lotions, oils, ointments and bathing agents, applicable to the skin of the human body, whether for medical or other reasons.
Particular examples of foodstuffs and beverages include, but are not limited to frozen confectionery such as ice creams and sorbets; desserts such as jelly and pudding;
confectionery such as cakes, cookies, chocolates, and chewing gum; jams; candies; breads; tea beverages such as green tea, black tea, chamomile tea, mulberry leaf tea, Rooibos tea, peppermint tea; soups; seasonings; instant beverages; snack foods and the like.
Further examples of products for topical application may include, but are not limited to, skin-care cosmetics such as cleansing tissues, talcum powders, face creams, lotions, tonics and gels; hand creams, hand- and body lotions, anti-cellulite/slimming creams and -lotions, lotions, balms, gels, sprays and creams; sunburn cosmetics including sunscreen lotions, balms, gels, sprays and creams; after sun lotions, sprays and creams; soaps, toothpicks, lip sticks, agents for bathing, deodorants and antiperspirants, face washing creams, massage creams, and the like, Further examples of products that are applied to the oral mucosa may include, but are not limited to, oral care products such as toothpastes, tooth gels, tooth powders, tooth whitening products, dental floss, anti-plaque and anti-gingivitis compositions,
mouthwashes, compositions for treatment of nasal symptoms, and the like. The compositions have been found to be particularly useful and effective in such oral care products.
The compositions of the invention may be added to and incorporated into a product base by known methods. Sufficient may be added to provide a cooling effect. The necessary proportion to provide such an effect will naturally depend on the desired cooling effect, but typical weight proportions being from 5 to 5000mg/kg, more particularly from 50 to
1500mg/kg. These are general guidelines, not rigid boundaries, and formulators seeking particular effects may find it possible or even desirable to formulate outside them. There is therefore also provided a product adapted to provide a cooling effect on the skin or the mucous membranes, the composition comprising a product base and a cooling proportion of a liquid cooling composition as hereinabove described. There is also provided a method of providing to a product a cooling sensation for the skin or the mucous membranes, comprising the addition to a product base of a cooling proportion of a liquid cooling composition as hereinabove described.
By "product base" is meant all the components of a product other than the liquid cooling mixture. These can vary considerably, depending on the nature of the product. For example, a consumable product cannot have non-consumable ingredients.
Typical non-limiting examples of components for use in product bases include matrix materials both liquid and solid, including gums, starches and starch derivatives, polysaccharides and polymeric materials both natural and artificial, flavours and fragrances, pigments, dyestuffs and colouring matters, solvents, thickeners, rheology and viscosity modifiers, surfactants and dispersion aids, preservatives, bactericides and fungicides. The final product not only has an enhanced cooling effect with respect to the addition of the equivalent amount of powder, but it is also is free from the potentially irritant effects of undissolved powders on skin on mucous membranes.
In addition to an enhanced performance, the handling of the liquid blend during manufacture of products is much easier than with powders, a feature that is particularly significant on an industrial scale, in which the handling of powders, especially those of potent cooling compounds, present a potentially considerable irritant problem for workers, as well as a potential explosion hazard. The disclosure is further described with reference to the following non-limiting examples.
Figure 1 depicts a ternary phase diagram, defining the outer limits of the claimed range of compositions. Figure 2 depicts a further ternary phase diagram, defining a particular embodiment of the claimed range of compositions. Figure 3 depicts a further ternary phase diagram, defining a particular embodiment of th claimed range of compositions. Figure 4 depicts a further ternary phase diagram, defining a particular embodiment of th claimed range of compositions.
The figures are derived from the testing of a range of combinations of the three cooling compounds, the actual results being shown in the following table:
"180" "190" menthyl lactate After Heating On cooling On standing %w/w %w/w %w/w to 100<€ to 20*€ 7days @ 20°C
0 0 100 Liquid Solid
12 10 78 Liquid Liquid Liquid + Haze 20 20 60 Liquid Liquid Liquid + Haze 12 30 58 Liquid Liquid Liquid 50 0 50 Liquid + Solids - 0 50 50 Liquid Liquid Liquid
26 26 48 Liquid Liquid + Solids
20 36 44 Liquid Liquid Liquid 15 50 35 Liquid Liquid Liquid 25 45 30 Liquid Liquid Liquid 50 20 30 Liquid + Solids - 10 80 10 Liquid Liquid Liquid 30 60 10 Liquid Liquid Liquid + Solids 50 40 10 Liquid + Solids - 70 20 10 Liquid + Solids - 100 0 0 Solid - 0 100 0 Liquid Solid
The various combinations were tested by first heating to Ι ΟΟ 'Ό, then again after allowing them to cool to 20 ^ and finally observations after standing for 7 days at 20 °C.
The various results are evaluated this:
Liquid - most desirable
Liquid + haze - not so desirable, but usable
Liquid + solids - undesirable
Solid - undesirable
Blank - previous result undesirable, so not tested further.
It can be seen that the most desirable combinations are liquid and remain liquid over a long period, making them easy to prepare and store.
Example
A mouthwash base was prepared by combining the following components...
To samples of the base were added 0.02%w/w of a combination of 180, 190 and menthyl lactate in the weight proportions 15:50:35. In one case, the combination was added as a mixture of the individual solid powders, in the other case as a liquid blend as hereinabove described.
It was noticeable that parts of the solid powders were difficult to dissolve, some proportion not dissolving at all. On the other hand, the liquid blend was easily incorporated into the base, and there is assurance that the blend has been homogeneously distributed through the mouthwash.
The resulting toothpaste formulations were tested by a panel of experienced testers. It was found that the formulations containing the liquid blend gave a noticeably enhanced cooling effect compared with the powders, even though the same proportions were used. It is believed that the difficulty of dissolving the powders was responsible for the lower cooling effect.
In addition, the addition of the liquid blend was much easier than with the powder, and the final product is free from the potentially irritant effects of undissolved powders on skin on mucous membranes.

Claims

Claims:
1 . A liquid cooling composition that is a mixture of (N-(4-cyanomethylphenyl) p- menthanecarboxamide, N-(2-pyridin-2-ylethyl) p-menthanecarboxamide and menthyl lactate, the composition being characterized in that, in a triangular ternary phase diagram of (N-(4-cyanomethyl-phenyl) p-menthanecarboxamide, N-(2- pyridin-2-ylethyl) p-menthanecarboxamide and menthyl lactate, the composition falls within that portion of the diagram bounded by the coordinates of the following table:
Figure imgf000010_0001
2. A liquid cooling mixture according to claim 1 , in which the mixture within that portion of the diagram bounded by the coordinates of the following table:
Figure imgf000010_0002
A liquid cooling mixture according to claim 1 , in which the mixture within that portion of the diagram bounded by the coordinates of the following table:
menthyl lactate (N-(4-cyanomethylphenyl) N-(2-pyridin-2-ylethyl) p- p-menthanecarboxamide, menthanecarboxamide
80 10 10
10 20 60
20 0 80
4. A liquid cooling mixture according to claim 1 , in which the mixture within that portion of the diagram bounded by the coordinates of the following table:
Figure imgf000011_0001
5. A liquid cooling mixture according to any one of claims 1 -4, in which all three
components are present in the mixture.
6. A product comprising a product base and a cooling effect-providing proportion of a liquid cooling composition according to claim 1 . 7. A product according to claim 6, in which the proportion of liquid cooling
composition is from 5 to 5000mg/kg, particularly from 50 to 1500mg/kg
8. A product according to claim 6, in which the product is an oral care product. 9. A method of providing to a product a cooling sensation for the skin or the mucous membranes, comprising the addition to a product base of a cooling effect-providing proportion of a liquid cooling composition according to claim 1 .
PCT/EP2018/054633 2017-02-27 2018-02-26 Cooling compositions Ceased WO2018154102A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1703136.0A GB201703136D0 (en) 2017-02-27 2017-02-27 Compositions
GB1703136.0 2017-02-27

Publications (1)

Publication Number Publication Date
WO2018154102A1 true WO2018154102A1 (en) 2018-08-30

Family

ID=58544330

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2018/054633 Ceased WO2018154102A1 (en) 2017-02-27 2018-02-26 Cooling compositions

Country Status (2)

Country Link
GB (1) GB201703136D0 (en)
WO (1) WO2018154102A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026040627A1 (en) * 2024-08-22 2026-02-26 思摩尔国际控股有限公司 Cooling agent composition, cooling agent solution, atomizing liquid and atomizer

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190643A (en) * 1971-02-04 1980-02-26 Wilkinson Sword Limited Compositions having a physiological cooling effect
EP1750525A2 (en) * 2004-05-28 2007-02-14 Millennium Specialty Chemicals, Inc. Physiological cooling compositions
US20110091531A1 (en) * 2008-05-22 2011-04-21 Giv Audan Sa Cooling Composition
US20150313817A1 (en) * 2012-11-27 2015-11-05 Basf Se Composition of menthol and menthyl lactate, its preparation and its use as a cooling, flavouring and/or fragrance agent
EP1556332B1 (en) * 2002-10-28 2016-10-05 Givaudan SA Coolant solutions and compositions comprising the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190643A (en) * 1971-02-04 1980-02-26 Wilkinson Sword Limited Compositions having a physiological cooling effect
EP1556332B1 (en) * 2002-10-28 2016-10-05 Givaudan SA Coolant solutions and compositions comprising the same
EP1750525A2 (en) * 2004-05-28 2007-02-14 Millennium Specialty Chemicals, Inc. Physiological cooling compositions
US20110091531A1 (en) * 2008-05-22 2011-04-21 Giv Audan Sa Cooling Composition
US20150313817A1 (en) * 2012-11-27 2015-11-05 Basf Se Composition of menthol and menthyl lactate, its preparation and its use as a cooling, flavouring and/or fragrance agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026040627A1 (en) * 2024-08-22 2026-02-26 思摩尔国际控股有限公司 Cooling agent composition, cooling agent solution, atomizing liquid and atomizer

Also Published As

Publication number Publication date
GB201703136D0 (en) 2017-04-12

Similar Documents

Publication Publication Date Title
US7208480B2 (en) Polysaccharide based gel
JP4261744B2 (en) Oral composition
WO2014157547A1 (en) Composition for oral cavity
JPH0665023A (en) Frigid agent and frigid composition composed of @(3754/24)-)-isopulegol
JPH08310931A (en) Inhibitor of glucosyltransferase and cleaning agent for oral cavity
WO2018154102A1 (en) Cooling compositions
JP2002302450A (en) Composition for oral cavity
JP6599515B2 (en) Astringent composition
JP6505358B2 (en) Astringent composition
TW201728320A (en) Synergistic effects of alkanolamine alkylamides and other moisturizing agents
CN112041030B (en) non-aqueous oral care composition
JP6489736B2 (en) Low astringency composition
CN116744890A (en) Oral composition
JP6628839B2 (en) Astringent composition
JP7034612B2 (en) Oral composition
JP2019073566A (en) Low astringency composition
JP5720416B2 (en) Gel oral composition and method for producing the same
CN111479548B (en) oral composition
JP2003267816A (en) Cosmetics
JP6348267B2 (en) Astringent composition
JP2026031128A (en) Oral composition
JP2026031218A (en) Oral composition
WO2022145160A1 (en) Composition for oral cavity
WO2024142417A1 (en) Active ingredient-retaining agent
JPS62410A (en) Cosmetic

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18708086

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18708086

Country of ref document: EP

Kind code of ref document: A1